Cart
Orders
Not available hereProduct Overview
LIPORASE inj. is a hyaluronidase medicine from Daehan Nupharm, supplied as a white lyophilized powder containing 1,500 IU per vial in a 10-vial box. It is classified as a prescription medicine in South Korea. For professional buyers comparing product specifications, the labeled strength describes enzyme activity per vial, not a liquid concentration. The Korean labeling describes uses involving increased penetration of specified injectable medicines and infusions, and promotion of excess tissue-fluid and blood resorption.
Key Features
- Defined vial potency: Each vial contains hyaluronidase 1,500 IU.
- Lyophilized presentation: White freeze-dried powder rather than a ready-to-use liquid.
- Pack configuration: The documented presentation contains 10 vials per box.
Composition & Specifications
| Specification | Product detail |
|---|---|
| Product name | LIPORASE inj. |
| Product company | Daehan Nupharm Co., Ltd. |
| Product category | Hyaluronidase prescription medicine in South Korea |
| Active ingredient and strength | Hyaluronidase 1,500 IU per vial |
| Listed excipient | Lactose hydrate |
| Formulation | White lyophilized powder in a colorless transparent vial |
| Packaging | 10 vials per box |
| Country of origin | South Korea |
The Korean product record identifies Daehan Nupharm's Hwaseong Plant 1 and lists Guju Pharmaceutical as an export contract manufacturer. Check the supplied carton for the manufacturing entity applicable to the specific batch.
Storage & Handling
The reviewed Korean labeling specifies storage in a sealed container at room temperature not exceeding 25°C and a shelf life of 36 months from manufacture. Follow the supplied market-specific labeling and printed expiry date; the labeled shelf life does not indicate the remaining shelf life of a particular shipment.
Labeling warns of severe allergic reactions and contraindicates use in patients with relevant product or bovine-protein hypersensitivity. Qualified healthcare professionals must review the complete prescribing information before use.
Frequently Asked Questions
Does 1,500 IU describe the vial or the whole box?
The strength is 1,500 IU per vial. The documented box contains 10 vials. This is an enzyme-activity specification, not a concentration in IU per mL.
Is filler reversal a documented Korean approved indication?
Filler reversal is not listed among the Korean indications reviewed for LIPORASE inj. The product should not be presented as having a Korean approved filler-reversal indication or guaranteed aesthetic outcomes.
Does Korean prescription status establish eligibility for purchase elsewhere?
No. Korean product authorization does not establish authorization in another country. Professional buyers must confirm destination-specific requirements for advertising, importation, supply and use before considering procurement.